 Connection
Nahed El-Hassan to Infant, Premature
This is a "connection" page, showing publications Nahed El-Hassan has written about Infant, Premature.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
1.095 |
|
|
|
-
ElHassan NO, Gourley GR, Pezeshkmehr A, Greenberg SB, Lewis PS, Lile SA. A Preterm Infant with Abdominal Distension and Bloody Stools. J Pediatr. 2019 Feb; 205:289-289.e1.
Score: 0.513
-
El Hassan N, Ryan R, Nirupama L. Premature infants: analysis of serum phosphate during the first 4 weeks of life. Am J Perinatol. 2007 May; 24(5):327-30.
Score: 0.233
-
ElHassan NO, Schaefer EW, Gonzalez B, Nienaber T, Brion LP, Kaiser JR. Early Transient Hypoglycemia and Test Performance in At-Risk Newborns. Am J Perinatol. 2023 07; 40(10):1096-1105.
Score: 0.156
-
ElHassan NO, Bird TM, King AJ, Ambadwar PB, Jaquiss RD, Kaiser JR, Robbins JM. Variation and comparative effectiveness of patent ductus arteriosus pharmacotherapy in extremely low birth weight infants. J Neonatal Perinatal Med. 2014 Jan 01; 7(3):229-35.
Score: 0.092
-
Elhassan NO, Sorbero ME, Hall CB, Stevens TP, Dick AW. Cost-effectiveness analysis of palivizumab in premature infants without chronic lung disease. Arch Pediatr Adolesc Med. 2006 Oct; 160(10):1070-6.
Score: 0.056
-
Elhassan NO, Stevens TP, Sorbero ME, Dick AW, Guillet R, Hall CB. Guidelines for palivizumab prophylaxis: are they based on infant's risk of hospitalization for respiratory syncytial viral disease? Pediatr Infect Dis J. 2003 Nov; 22(11):939-43.
Score: 0.046
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|